WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) Chief Executive Officer Neal Walker will address investors Sept. 10 at the Cantor Global Healthcare Conference in New York as the clinical-stage biotechnology company advances a portfolio of experimental treatments for immuno-inflammatory diseases.
Walker is scheduled to participate in a fireside chat at 2:45 p.m. ET, according to Aclaris.
The appearance gives investors an opportunity to hear from management as the Wayne-based company develops product candidates across multiple stages of development for diseases where patients lack satisfactory treatment options.
Aclaris did not identify specific clinical programs or milestones that Walker plans to discuss at the conference.
A live webcast will be available through the Events page of the company’s website at www.aclaristx.com. An archived version will remain available for at least 30 days.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.